medigraphic.com

2013, Número 1

<< Anterior

Rev Mex Med Repro 2013; 5.6 (1)


50º Congreso Mexicano de Medicina de la Reproducción

Idioma: Español
Referencias bibliográficas: 59
Paginas: 19-80
Archivo PDF: 553.05 Kb.


FRAGMENTO

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Sherman JK. Synopsis of the use of frozen human semen since 1964: state of the art of human semen banking. Fertil Steril,1973;24:397-412.

  2. Sanger WG, Olson JH, Sherman JK. Semen cryobanking for men with cancer—criteria change. Fertil Steril 1992;58:1024-1027.

  3. Jensen JR, Morbeck DE, Coddington CCC III. Fertility preservation. Mayo Clinic Proc 2011;86:45-49.

  4. Anger JT, Gilbert BR, Goldstein M. Cryopreservation of sperm: indications, methods and results. J Urol 2003;170:1079-1084.

  5. Morris GJ, Acton E, Avery S. A novel approach to sperm cryopreservation. Hum Reprod 1999;14:1013-1021.

  6. Donnelly ET, McClure N, Lewis SEM. Cryopreservation of human semen and prepared sperm: effects on motility parameters and DNA integrity. Fertil Steril 2001;76:892-900.

  7. Edwards RG, et al. Preliminary attempts to fertilize human oocytes matured in vitro. Am J Obstet Gynecol 1966;15:192- 200.

  8. Wood C, et al. Transfer of a human zygote. Lancet 1973;29:728-729.

  9. Chang MC. Fertilization of rabbit ova in vitro. Nature 1959;8:184.

  10. Steptoe PC, Edwards RG. Birth after the reimplantation of a human embryo. Lancet 1978;12:366.

  11. Muasher SJ, Abdallah RT, Hubayter ZR. Optimal stimulation protocols for in vitro fertilization. Fertil Steril 2006;86:267- 273.

  12. Palermo G, Joris H, Devroey P, Van Steirtteghem AC. Pregnancies after intracytoplasmatic injection of single spermatozoon into an oocyte. Lancet 1992;2:17-18.

  13. Gardner DK, Lane M. Culture and selection of viable blastocysts: a feasible proposition for Human IVF? Hum Reprod Update 1997;4:367-382.

  14. Arellano-Carillo MD, et al. Aplicación de calmodulina como capacitador espermático. Rev Mex Reprod 2011;4:86-91.

  15. Carballo-Mondragón E, et al. Comparación de tres métodos de capacitación espermática para ICSI en pacientes con morfología anormal. Rev Mex Reprod 2011;4:68-71.

  16. Quezada-Casasola A, et al. Cultivo de embriones a través de un medio modificado para aumentar la preñez en ganado bovino. CULCyT 2013;10:10-14.

  17. Ford W, et al. Glycolisis and sperm motility: does a spoondful of sugar help the flagellum go round? Hum Reprod Update 2006;12:269-74.

  18. Pérez Peña E. Atención Integral de la Infertilidad. 3ª ed. Panamericana, 2011;565-81.

  19. Chung K, Irani J, Knee G, Efymow B, Blasco L, Patrizio P. Sperm cryopreservation for male patients with cancer: an epidemiological analysis at the University of Pennsylvania Eur J Obstet Gynecol Reprod Biol. 2004;113: S7-11.

  20. Lass A, Akagbosu F, Abusheikha N, Hassouneh M, Blayney M, Avery S, Brinsden P. A programme of semen cryopreservation for patients with malignant disease in a tertiary infertility centre: lessons from 8 years’ experience. Hum Reprod 1998;13:3256-61.

  21. Raziel A, Friedler S. Increased frequency of female partner chromosomal abnormalities in patients with high-order implantation failure after in vitro fertilization. Fertil Steril 2002;78:3.

  22. Farr SL, Schieve LA, Jamieson DJ. Pregnancy loss among pregnancies conceived through assisted reproductive technology, United States, 1999-2002. Am J Epidemiology 2007;165:1380-1388.

  23. Won JK, Lee WS, Yoon TK, et al. Chromosomal abnormalities in spontaneous abortion after assisted reproductive treatment. BMC Medical Genetic 2010; 11:153.

  24. Hsu LYF. Prenatal diagnosis of chromosomal abnormalities through amniocentesis. In: Milunsky A, editor. Genetic disorders and the fetus. 4th ed. The Johns Hopkins University Press, 1998.

  25. Warburton D, Kline J, Stein Z, et al. Cytogenetic abnormalities in spontaneous abortions of recognized conception. In: Porter IH, Willey A, editors. Perinatal genetics diagnosis and treatment. Academic Press, 1986;133.

  26. Van Shten-Arends J, Mastenbroek S, Sikkema-Raddatz B. Cromosomal mosaicism in human preimplantation embryos: A systematic review. Human Reprod 2011;17:620-627.

  27. Reiss HE. Reproductive medicine: From A to Z. Oxford University Press, 1998; 168.

  28. Meka A, Mohan BR. Recurrent spontaneous abortion: An overview of genetic and non-genetic backgrownds. Int J Hum Genet 2006;6:109-117.

  29. Hodes-Wertz B, Grifo J, Ghadir S, et al. Idiopathic recurrent miscarriage is caused mostly be aneuploid embryos. Fertil Steril 2012;98:675-680.

  30. Feskov AM, Arbuzova SB, Grabar VV. Genetic aspects of infertility and miscarriage – a review of literature. Arch Perinatal Med 2009;15:152-158.

  31. Hassold TJ. A cytogenetic study of repeated spontaneous abortions. Am J Hum Genet 1980;32:723-730.

  32. McWeeney DT, Munné S, Miller RC, et al. Pregnancy complicated by triploidy: a comparison of the three karyotypes. Am J Perinatol 2009;29:641.

  33. Kushnir VA, Frattarelli JL. Aneuploidy in abortuses following IVF and ICSI. J Assist Reprod Genet 2009;26:93-97.

  34. Lipscomb GH, McCord ML. Stovall TG, Huff G, Portera SG, Ling FW. Predictors of success of methotrexate treatment in woman with tubal ectopic pregnancies. N Engl J Med 1999;341:1974-1978.

  35. Lipscomb GH, Brand D, McCord ML, Portera JC, Ling FW. Analysis of three hundred fifteen ectopic pregnancies treated with single dose methotrexate. Am J Obstet Gynecol 1998;178:1354-1358.

  36. Cepni I, Güralp O, Öcal P, Salahov R, Gurleyen H, Idil M. An alternative treatment option in tubal ectopic pregnancies with fetal heartbeat: aspiration of the embryo followed by single dose methotrexate administration. Fertil Steril 2011;96:79- 83.

  37. Gurtcheff SE, Hatasaka H, Lambert P, Empey R, Morris E, Hammoud A, Clinical presentation of Mullerian anomalies in a large population cohort. Fertil Steril 2008;90:S153-S154.

  38. Acien P, Acien MI. The history of female genital tract malformation classifications and proposal of an updated system. Hum Reprod 2011;17:693-705.

  39. Chandler TM, Machan LS, Cooperberg PL. Müllerian duct anomalies: from diagnosis to intervention: BJR 2009:1034- 1042

  40. Fedele L. Bianchi S, Agnoli B, Tozzi L, Vignali M. Urinary tract anomalies associated with unicornuate uterus. J Urol 1996;155:847-848.

  41. Morales R. Fragmentación del ADN espermático y su implicación en la fertilidad. Revista Iberoamericana de Fertilidad 2007;24.

  42. Smith RK. Aumento del daño en el ADN y estrés oxidativo en espermatozoides de pacientes con oligozoospermia idiopática y antecedentes de criptoquidismo. Rev Médica Chile 2007;135:279-286.

  43. Cortes-Gutierrez, Davila R, Lopez C, Fernandez J, Gonsalvez J. Evaluación del daño en el DNA espermático. Actas Urol Esp 2007;31:120-131.

  44. Bungum M, Humaidan P, Spano M, Jepson K, et al. The predictive value of sperm chromatin structure assay (SCSA) parameters for the outcome of intrauterine insemination, IVF and ICSI. Hum Reprod 2004;19:1401-1408.

  45. Evenson DP, Jost LK, Marshall D, Zinaman MJ, et al. Utility of the sperm chromatin structure assay as a diagnostic and prognostic tool in the human fertility clinic. Hum Reprod 1999;14:1039-1049.

  46. Muriel L, Goyanes V, Segrelles E, Gosalvez J, et al. Increased aneuploidy rate in sperm with fragmented DNA as determined by the sperm chromatin dispersion (SCD) test and FISH analysis. J Androl 2007;28:38-49.

  47. Alternatives to hysterectomy in the management of leiomyomas. ACOG Practice Bulletin No. 96. American College of Obstetricians and Gynecologist. Obstet Gynecol 2008;112:387-400.

  48. Falcone T, Parker WH. Surgical management of leiomyomas for fertility or uterine preservation. CME Obstet Gynecol 2013;121:856-68.

  49. Laughlin SK, Stewart EA. Uterine leiomyomas individualizing the approach to a heterogeneous condition. Obstet Gynecol 2011;117:396-403.

  50. Van der Koij et al. Review of nonsurgical/minimally invasive treatments for uterine fibroids. Curr Opin Obstet Gynecol 2012;24:368-75.

  51. Spies JB, Bradley LD, Guido R, Maxwell GL, Levine BA, Coyne K. Outcomes from leiomyoma therapies: comparison with normal controls. Obstet Gynecol 2010;116:641-52.

  52. Zurawin RK, Dietrich JE, Heard MJ, Edwards CL. Didelphic uterus and obstructed hemivagina with renal agenesis: case report and review of the literature. J Pediatr Adolesc Gynecol 2004;17:137-41.

  53. Burgis J. Obstructive Müllerian anomalies: Case report, diagnosis, and management. Am J Obstet Gynecol 2001;185:338-44.

  54. Del Vescovo et al. Herlyn-Werner-Wunderlich syndrome: MRI findings, radiological guide (two cases and literature review), and differential diagnosis BMC Medical Imaging 2012;12:4,1-10.

  55. Vivier PH, et al. Uterus didelphys, hemihydrocolpos and empty ipsilateral lumbar fossa in a newborn girl: involuted dysplastic kidney rather than renal agenesis Pediatr Radiol 2011;41:1205-1207.

  56. Schutt AK, Barret MR, Trotta BM, Stovall DW. Perioperative evaluation in Herlyn-Werner-Wunderlich syndrome. Obstet Gynecol 2012;120:948-51.

  57. Barad D, Gleicher N. Increased oocyte production, after treatment with dehydroepiandrosterone. Fertil Steril 2005;84:756.

  58. Kroboth PD, Salek FS, Pittenger AL, Fabian TJ, Frye RF. DHEA and DHEA-S: a review. J Clin Pharmacol 1999;39:327-348.

  59. Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone concentrations throughout adulthood. J. Clin Endocrinol Metab 1984;59:551-555.




2020     |     www.medigraphic.com